tm
Seeing Is Believing
tm
Seeing Is Believing
ABCL is currently covered by 4 analysts with an average potential upside of $19.09 (167.35%) backed by displayed 7 price targets and 19 ratings.
Analysts average stock forecasts to be materialized ratio is 5% with an average time for these price targets to be met of 46.75 days.
Highest price target for ABCL is 16, Lowest price target is 6, average price target is 11.
Most recent stock forecast was given by TIAGO FAUTH from CREDIT SUISSE on 22-Feb-2023. First documented stock forecast 25-Jan-2021.
Currently, out of the existing stock ratings of ABCL - 14 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
34
$28.92 (569.29%)
34
6 months 30 days ago
0/4 (0%)
$24.05 (212.56%)
Buy
32
$26.92 (529.92%)
50
6 months 30 days ago
0/2 (0%)
$26.28 (203.09%)
Buy
21
$15.92 (313.39%)
22
8 months 1 days ago
0/7 (0%)
$15.17 (154.55%)
Buy
18
$12.92 (254.33%)
20
8 months 15 days ago
1/5 (20%)
$10.87 (99.20%)
187
What is ABCL (AbCellera Biologics) average time for price targets to be met?
Which analyst has the current highest performing score on ABCL (AbCellera Biologics) with a proven track record?
Which analyst has the current lower performing score on ABCL (AbCellera Biologics) with a proven track record?
Which analyst has the most public recommendations on ABCL (AbCellera Biologics)?
Which analyst is the currently most bullish on ABCL (AbCellera Biologics)?
Which analyst is the currently most reserved on ABCL (AbCellera Biologics)?
